Literature DB >> 24519035

Long-term outcome of patients with locally resected high- and low-risk rectal carcinoid tumors.

Kohei Shigeta1, Koji Okabayashi, Hirotoshi Hasegawa, Yoshiyuki Ishii, Hiroki Ochiai, Masashi Tsuruta, Makio Mukai, Kaori Kameyama, Toshio Uraoka, Naohisa Yahagi, Yuko Kitagawa.   

Abstract

BACKGROUND: Tumor size and lymphovascular invasion are known high-risk factors for lymph node and distant metastasis in patients with rectal carcinoid tumors. However, the optimal treatment for these tumors remains controversial. AIM: The aim of this paper is to compare the outcome of local or radical resection between patients with high-risk (tumor size >10 mm or lymphovascular invasion) disease and those with low-risk (tumor size ≤10 mm, no lymphovascular invasion) disease.
METHODS: Patients with rectal carcinoid tumors treated between January 1990 and March 2010 were identified retrospectively and classified into low- and high-risk groups.
RESULTS: In total, 83 patients with rectal carcinoid tumors were included, 53 (64%) of whom were identified as low-risk and 30 (36%) as high-risk. Local resection was performed in 50 (60%) low-risk and 24 (29%) high-risk patients, and postoperative recurrence was observed in one (1%) of the high-risk patients who underwent local resection and one (11%) who underwent radical resection. No recurrence was observed in the low-risk group. Kaplan-Meier analysis of the patients who underwent local resection revealed that the 10-year disease-free survival rate was 100% in the low-risk group and 83.3% in the high-risk group.
CONCLUSIONS: There was no significant difference in outcome between local and radical resection.

Entities:  

Mesh:

Year:  2014        PMID: 24519035     DOI: 10.1007/s11605-014-2468-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

1.  Effectiveness of local endoscopic resection of rectal carcinoid tumors.

Authors:  S Higaki; M Nishiaki; N Mitani; H Yanai; M Tada; K Okita
Journal:  Endoscopy       Date:  1997-03       Impact factor: 10.093

2.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  Endoscopic submucosal dissection or conventional endoscopic mucosal resection is an effective and safe treatment for rectal carcinoid tumors: a retrospective study.

Authors:  Il Hyun Baek
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2010-05       Impact factor: 1.878

4.  Management of early gastrointestinal neuroendocrine neoplasms.

Authors:  Hans Scherübl; Robert T Jensen; Guillaume Cadiot; Ulrich Stölzel; Günter Klöppel
Journal:  World J Gastrointest Endosc       Date:  2011-07-16

Review 5.  Carcinoids of the rectum.

Authors:  S Mani; I M Modlin; G Ballantyne; H Ahlman; B West
Journal:  J Am Coll Surg       Date:  1994-08       Impact factor: 6.113

6.  The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Authors:  Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 7.  Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.

Authors:  Jun Soga
Journal:  Cancer       Date:  2005-04-15       Impact factor: 6.860

8.  Anorectal carcinoid tumors. Is aggressive surgery warranted?

Authors:  P Sauven; J A Ridge; S H Quan; E R Sigurdson
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

9.  Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases.

Authors:  Mitsuhiro Fujishiro; Naohisa Yahagi; Naomi Kakushima; Shinya Kodashima; Yosuke Muraki; Satoshi Ono; Nobutake Yamamichi; Ayako Tateishi; Masashi Oka; Keiji Ogura; Takao Kawabe; Masao Ichinose; Masao Omata
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-26       Impact factor: 11.382

10.  Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Authors:  James C Yao; Alexandria T Phan; David Z Chang; Robert A Wolff; Kenneth Hess; Sanjay Gupta; Carmen Jacobs; Jeannette E Mares; Andrea N Landgraf; Asif Rashid; Funda Meric-Bernstam
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

View more
  10 in total

1.  Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.

Authors:  Masau Sekiguchi; Shigeki Sekine; Taku Sakamoto; Yosuke Otake; Takeshi Nakajima; Takahisa Matsuda; Hirokazu Taniguchi; Ryoji Kushima; Yuichiro Ohe; Yutaka Saito
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

2.  The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.

Authors:  Shinya Sugimoto; Kinichi Hotta; Tadakazu Shimoda; Kenichiro Imai; Yuichiro Yamaguchi; Takashi Nakajima; Takuma Oishi; Keita Mori; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2015-12-30       Impact factor: 4.584

3.  Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas.

Authors:  Derek J Erstad; Arvind Dasari; Melissa W Taggart; Harmeet Kaur; Tsuyoshi Konishi; Brian K Bednarski; George J Chang
Journal:  Ann Surg Oncol       Date:  2021-11-17       Impact factor: 5.344

4.  Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors.

Authors:  Lianhuang Li; Liwei Jiang; Zhifen Chen; Deyong Kang; Zhenrong Yang; Xing Liu; Weizhong Jiang; Shuangmu Zhuo; Guoxian Guan; Yongjian Zhou; Jianxin Chen
Journal:  Lasers Med Sci       Date:  2016-06-14       Impact factor: 3.161

5.  Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.

Authors:  Mi Jung Kwon; Ho Suk Kang; Jae Seung Soh; Hyun Lim; Jong Hyeok Kim; Choong Kee Park; Hye-Rim Park; Eun Sook Nam
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

6.  Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis.

Authors:  Yoshiyasu Kitagawa; Dai Ikebe; Taro Hara; Kazuki Kato; Teisuke Komatsu; Fukuo Kondo; Ryousaku Azemoto; Fumitake Komoda; Taketsugu Tanaka; Hirofumi Saito; Makiko Itami; Taketo Yamaguchi; Takuto Suzuki
Journal:  Cancer Med       Date:  2016-10-17       Impact factor: 4.452

7.  Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.

Authors:  Qiaoqi Sui; Junzhong Lin; Jianhong Peng; Yujie Zhao; Yuxiang Deng; Zhizhong Pan
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

8.  Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.

Authors:  Seung-Joo Nam; Byung Chang Kim; Hee Jin Chang; Han Ho Jeon; Junho Kim; Su Young Kim
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

Review 9.  Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.

Authors:  Camilla Gallo; Roberta Elisa Rossi; Federica Cavalcoli; Federico Barbaro; Ivo Boškoski; Pietro Invernizzi; Sara Massironi
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

10.  Metachronous liver metastases after long-term follow-up of endoscopic resection for rectal neuroendocrine neoplasms: a report of three cases.

Authors:  Yuma Hane; Takahiro Tsuchikawa; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Takehiro Noji; Yo Kurashima; Yuma Ebihara; Soichi Murakami; Toru Nakamura; Keisuke Okamura; Satoshi Takeuchi; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surg Case Rep       Date:  2020-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.